About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Asap1Gt(RRS873)Byg
gene trap RRS873, BayGenomics
MGI:4332097
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Asap1Gt(RRS873)Byg/Asap1Gt(RRS873)Byg FVB.129P2(B6)-Asap1Gt(RRS873)Byg MGI:6358633


Genotype
MGI:6358633
hm1
Allelic
Composition
Asap1Gt(RRS873)Byg/Asap1Gt(RRS873)Byg
Genetic
Background
FVB.129P2(B6)-Asap1Gt(RRS873)Byg
Cell Lines RRS873
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Asap1Gt(RRS873)Byg mutation (1 available); any Asap1 mutation (60 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• homozygotes that survive the first day after birth are viable with equivalent longevity to wild-type littermates
• although present at normal Mendelian ratios from E11.5 to E18.5, the number of homozygotes is significantly reduced at P0, suggesting lethality during or directly after birth

growth/size/body
• neonates show reduced body weight relative to wild-type controls
• at 18 months of age, males show a significantly lower body weight than wild-type controls, with a similar trend observed in females
• males gain significantly less weight than wild-type males from 10 to 40 weeks of age
• however, females show normal weight gain
• body size is significantly reduced at E15.5
• body weight is significantly reduced at E18.5 and P0
• body size is significantly reduced from E15.5 onwards

respiratory system
• respiratory rate is significantly reduced at P0
• however, respiratory rate is recovered in neonates that survive the first day after birth and surviving pups reach adulthood

skeleton
• shorter skulls at E15.5
• at E15.5, ossification of the frontal bone of the cranial vault is delayed
• at E15.5, ossification of the mandible is delayed
• at E15.5, ossification of the premaxilla is delayed
• at E18.5, ossification of the proximal and distal phalanges is delayed
• femur width is significantly reduced at E15.5 and E18.5
• femur length is significantly reduced at E15.5 but not at E18.5
• at E15.5, the length of the hypertrophic zone in humeral growth plates is increased; the expression area of the hypertrophic marker collagen X and the osteogenic markers osteocalcin and osteopontin is expanded
• at E15.5, the chondro-osseous junction in humeral growth plates appears disorganized, indicating premature hypertrophy
• at E15.5, size and ossification of the lumbar vertebrae is reduced
• limb bud mass cultures from E11.5 embryos show a trend towards increased Alcian Blue staining (proteoglycan synthesis) and significantly increased transcription of chondrogenic markers (aggrecan and Indian hedgehog) relative to wild-type cultures, indicating accelerated in vitro chondrogenic differentiation
• at E15.5, ossification of the lumbar vertebrae is delayed
• at E18.5, ossification of the proximal and distal phalanges is delayed
• at E15.5, ossification of the frontal bone of the cranial vault, the premaxilla and the mandible is delayed
• after 14 days of osteogenic differentiation-inducing treatment, primary MEFs show no von Kossa or Alizarin Red staining, unlike wild-type MEFs; also, no increase in expression of the osteogenic transcription factor osterix and the matrix proteins osteocalcin and bone sialoprotein is observed, indicating impaired in vitro osteogenic differentiation
• dysregulation of FAK/Src-PI3K/AKT signaling in MEFs may contribute to reduced osteogenic differentiation

adipose tissue
• mice exhibit a defect in the generation of adipocytes and the accumulation of lipids, indicating reduced adipogenesis
• after 7 days of adipogenic differentiation-inducing treatment, primary MEFs show poor Oil Red O staining, unlike wild-type MEFs; no subsequent high induction of PPARgamma and C/EBPalpha, or later expression of the adipogenic markers adiponectin and Glut4 is observed, indicating impaired in vitro adipocyte differentiation
• FAK/Src-PI3K/AKT signaling pathway is dysregulated in MEFs; however, no differences in focal adhesion formation or cell adhesion are observed
• neonates exhibit significantly fewer lipid-filled (perilipin A-positive) subcutaneous adipocytes in the scapular region relative to wild-type controls
• at 18 months of age, the size of adipocytes in perigonadal WAT is significantly deceased
• at 18 months of age, perigonadal fat pad weight is significantly decreased in both sexes
• at 18 months of age, retroperitoneal fat pad weight is significantly decreased in males, with a similar trend observed in females

cellular
• in vitro, mesenchymal progenitor cells show enhanced differentiation into chondrocytes, but impaired differentiation into adipocytes and osteoblasts
• impaired adipogenic differentiation in MEFs is rescued by FAK activation while defective adipogenic and osteogenic differentiation are both associated with dysregulated Src and AKT signaling
• after 7 days of adipogenic differentiation-inducing treatment, primary MEFs show poor Oil Red O staining, unlike wild-type MEFs; no subsequent high induction of PPARgamma and C/EBPalpha, or later expression of the adipogenic markers adiponectin and Glut4 is observed, indicating impaired in vitro adipocyte differentiation
• FAK/Src-PI3K/AKT signaling pathway is dysregulated in MEFs; however, no differences in focal adhesion formation or cell adhesion are observed

craniofacial
• shorter skulls at E15.5
• at E15.5, ossification of the frontal bone of the cranial vault is delayed
• at E15.5, ossification of the mandible is delayed
• at E15.5, ossification of the premaxilla is delayed

limbs/digits/tail
• at E18.5, ossification of the proximal and distal phalanges is delayed
• at E15.5, size and ossification of the hind limbs is reduced
• femur width is significantly reduced at E15.5 and E18.5
• femur length is significantly reduced at E15.5 but not at E18.5

cardiovascular system
N
• neonates exhibit no obvious vascular defects
• retinal angiogenesis and lymphangiogenesis are normal

neoplasm
N
• mice do not exhibit any predisposition to develop tumors





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory